{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T16:27:42Z","timestamp":1785688062405,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T00:00:00Z","timestamp":1671321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T00:00:00Z","timestamp":1671321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1245\/s10434-022-12891-5","type":"journal-article","created":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T20:02:38Z","timestamp":1671393758000},"page":"2691-2698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Is Thoracic Duct Resection Necessary for Esophageal Squamous Cell Carcinoma Patients Treated with Neoadjuvant Chemoradiotherapy? A Propensity-Matched Analysis Based on the Comprehensive Registry of Esophageal Cancer in Japan"],"prefix":"10.1245","volume":"30","author":[{"given":"Taro","family":"Oshikiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hodaka","family":"Numasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Oguma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kakeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,18]]},"reference":[{"key":"12891_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"12891_CR2","first-page":"579","volume-title":"Cancer epidemiology and prevention","author":"WJ Blot","year":"2018","unstructured":"Blot WJ, Tarone RE, et al. Esophageal cancer. In: M Thun, MS Linet, JR Cerhan, et al., editors. Cancer epidemiology and prevention. 4th edn. Oxford: Oxford University Press; 2018. p. 579\u201393.","edition":"4"},{"key":"12891_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/SLA.0b013e31817bbe59","volume":"248","author":"NK Altorki","year":"2008","unstructured":"Altorki NK, Zhou XK, Stiles B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008;248:221\u20136.","journal-title":"Ann Surg"},{"key":"12891_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/SLA.0b013e318188c474","volume":"248","author":"CG Peyre","year":"2008","unstructured":"Peyre CG, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248:549\u201356.","journal-title":"Ann Surg"},{"key":"12891_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.athoracsur.2018.02.047","volume":"106","author":"B Schurink","year":"2018","unstructured":"Schurink B, Defize IL, Mazza E, et al. Two-field lymphadenectomy during esophagectomy: the presence of thoracic duct lymph nodes. Ann Thorac Surg. 2018;106:435\u20139.","journal-title":"Ann Thorac Surg"},{"key":"12891_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s10388-014-0433-9","volume":"11","author":"H Udagawa","year":"2014","unstructured":"Udagawa H, Ueno M, Shinohara H, et al. Should lymph nodes along the thoracic duct be dissected routinely in radical esophagectomy? Esophagus. 2014;11:204\u201310.","journal-title":"Esophagus"},{"key":"12891_CR7","doi-asserted-by":"publisher","first-page":"e3839","DOI":"10.1097\/MD.0000000000003839","volume":"95","author":"S Matsuda","year":"2016","unstructured":"Matsuda S, Takeuchi H, Kawakubo H, et al. Clinical outcome of transthoracic esophagectomy with thoracic duct resection: number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct. Medicine (Baltimore). 2016;95:e3839.","journal-title":"Medicine (Baltimore)"},{"key":"12891_CR8","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1245\/s10434-019-07627-x","volume":"26","author":"T Oshikiri","year":"2019","unstructured":"Oshikiri T, Takiguchi G, Miura S, et al. Thoracic duct resection during esophagectomy does not contribute to improved prognosis in esophageal squamous cell carcinoma: a propensity score matched-cohort study. Ann Surg Oncol. 2019;26:4053\u201361.","journal-title":"Ann Surg Oncol"},{"key":"12891_CR9","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1245\/s10434-019-07304-z","volume":"26","author":"N Yoshida","year":"2019","unstructured":"Yoshida N, Nagai Y, Baba Y, et al. Effect of resection of the thoracic duct and surrounding lymph nodes on short- and long-term and nutritional outcomes after esophagectomy for esophageal cancer. Ann Surg Oncol. 2019;26:1893\u2013900.","journal-title":"Ann Surg Oncol"},{"key":"12891_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005340","author":"T Oshikiri","year":"2021","unstructured":"Oshikiri T, Numasaki H, Oguma J, et al. Prognosis of patients with esophageal carcinoma following routine thoracic duct resection: a propensity-matched analysis of 12,237 patients based on the comprehensive registry of esophageal cancer in Japan. Ann Surg. 2021. https:\/\/doi.org\/10.1097\/SLA.0000000000005340.","journal-title":"Ann Surg"},{"key":"12891_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/bjs\/znaa121","volume":"108","author":"SK Kamarajah","year":"2021","unstructured":"Kamarajah SK, Phillips AW, Ferri L, Hofstetter WL, Markar SR. Neoadjuvant chemoradiotherapy or chemotherapy alone for oesophageal cancer: population-based cohort study. Br J Surg. 2021;108:403\u201311.","journal-title":"Br J Surg"},{"key":"12891_CR12","volume-title":"TNM classification of malignant tumors","author":"LH Sobin","year":"2010","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors. 7th edn. Oxford: Wiley-Blackwell; 2010.","edition":"7"},{"key":"12891_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","volume":"41","author":"S Crotty","year":"2014","unstructured":"Crotty S. T follicular helper cell differentiation, function, and roles in disease. Immunity. 2014;41:529\u201342.","journal-title":"Immunity"},{"key":"12891_CR14","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1126\/science.1175870","volume":"325","author":"RJ Johnston","year":"2009","unstructured":"Johnston RJ, Poholek AC, DiToro D, et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science. 2009;325:1006\u201310.","journal-title":"Science"},{"key":"12891_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","volume":"29","author":"S Crotty","year":"2011","unstructured":"Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29:621\u201363.","journal-title":"Annu Rev Immunol"},{"key":"12891_CR16","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1172\/JCI125628","volume":"129","author":"LA Vella","year":"2019","unstructured":"Vella LA, Buggert M, Manne S, et al. T follicular helper cells in human efferent lymph retain lymphoid characteristics. J Clin Investig. 2019;129:3185\u2013200.","journal-title":"J Clin Investig"},{"key":"12891_CR17","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1172\/JCI130311","volume":"129","author":"S Pahwa","year":"2019","unstructured":"Pahwa S. Searching for the origin of the enigmatic circulating T follicular helper cells. J Clin Investig. 2019;129:3048\u201351.","journal-title":"J Clin Investig"},{"key":"12891_CR18","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/SLA.0000000000000965","volume":"260","author":"A Koen Talsma","year":"2014","unstructured":"Koen Talsma A, Shapiro J, Looman CW, et al. Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival. Ann Surg. 2014;260:786\u201392.","journal-title":"Ann Surg"},{"key":"12891_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/ags3.12432","volume":"5","author":"S Matsuda","year":"2021","unstructured":"Matsuda S, Kawakubo H, Takeuchi H, et al. Prognostic impact of thoracic duct lymph node metastasis in esophageal squamous cell carcinoma. Ann Gastroenterol Surg. 2021;5:321\u201330.","journal-title":"Ann Gastroenterol Surg"},{"key":"12891_CR20","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MC, van Lanschot JJ, CROSS Group, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074\u201384.","journal-title":"N Engl J Med"},{"key":"12891_CR21","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1200\/JCO.20.03614","volume":"39","author":"BM Eyck","year":"2021","unstructured":"Eyck BM, van Lanschot JJB, Hulshof MCCM, CROSS Study Group, et al. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial. J Clin Oncol. 2021;39:1995\u20132004.","journal-title":"J Clin Oncol"},{"key":"12891_CR22","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","volume":"36","author":"H Yang","year":"2018","unstructured":"Yang H, Liu H, Chen Y, AME Thoracic Surgery Collaborative Group, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol. 2018;36:2796\u2013803.","journal-title":"J Clin Oncol"},{"key":"12891_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/SLA.0000000000001905","volume":"265","author":"S Pasquali","year":"2017","unstructured":"Pasquali S, Yim G, Vohra RS, et al. Survival after neoadjuvant and adjuvant treatments compared to surgery alone for resectable esophageal carcinoma: a network meta-analysis. Ann Surg. 2017;265:481\u201391.","journal-title":"Ann Surg"},{"key":"12891_CR24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1001\/jamasurg.2021.0133","volume":"156","author":"H Wang","year":"2021","unstructured":"Wang H, Tang H, Fang Y, et al. Morbidity and mortality of patients who underwent minimally invasive esophagectomy after neoadjuvant chemoradiotherapy vs neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma: a randomized clinical trial. JAMA Surg. 2021;156:444\u201351.","journal-title":"JAMA Surg"},{"key":"12891_CR25","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","volume":"384","author":"RJ Kelly","year":"2021","unstructured":"Kelly RJ, Ajani JA, Kuzdzal J, CheckMate 577 Investigators, et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med. 2021;384:1191\u2013203.","journal-title":"N Engl J Med"},{"key":"12891_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1245\/s10434-011-2049-9","volume":"19","author":"N Ando","year":"2012","unstructured":"Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68\u201374.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12891-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12891-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12891-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T14:05:13Z","timestamp":1681135513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12891-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,18]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["12891"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12891-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,18]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Taro Oshikiri, Hodaka Numasaki, Junya Oguma, Yasushi Toh, Masayuki Watanabe, Manabu Muto, Yoshihiro Kakeji, and Yuichiro Doki have no conflict of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}